A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults

PURPOSE/BACKGROUND: Psychostimulant augmentation is considered a potential treatment strategy for individuals with major depressive disorder who do not adequately respond to antidepressant monotherapy. The primary objective of this 12-month open-label extension study was to evaluate the safety and t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Psychopharmacol
Main Authors: Richards, Cynthia, Iosifescu, Dan V., Mago, Rajnish, Sarkis, Elias, Geibel, Brooke, Dauphin, Matthew, McIntyre, Roger S., Weisler, Richard, Brawman-Mintzer, Olga, Gu, Joan, Madhoo, Manisha
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2018
Assuntos:
Original Contributions
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6039401/
https://ncbi.nlm.nih.gov/pubmed/29912786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000000897
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados